I seem to remember that the FDA controls the classification but it takes its lead from the DEA, who obviously would want, in the name of self-interest, to keep it at Schedule 1. Of course marijuana strains have a variety of medicinal effects, but the FDA deals with single synthesized compounds from pharma that have undergone massive double-blind, placebo-controlled studies of patients with specific illnesses. The FDA is not structured to make rulings about plant material. Reply